Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EONS 2018 | Promoting nurse-led services in oncology

Matthew Fowler • 22 Oct 2018
EONS 2018 ESMO 2018
General

Matthew Fowler, BScN, MSc, from the Heart of England NHS Foundation Trust, Birmingham, UK, shares insights from the European Oncology Nurses Society (EONS) session on nurse-led cancer services, held at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany. Mr Fowler discusses his positive experiences of working as part of a medical team, who have provided support to allow for nurses to take on advanced practises, such as non-medical prescribing and chemotherapy administration. Due to such initiatives, many clinics are now nurse-led and there are numerous programmes in place to encourage and support nurses to take on additional qualifications and roles.

More from Matthew Fowler

EONS safety work: Where do we go from here?
2:07
EONS safety work: Where do we go from here?
Matthew Fowler • 24 Sep 2020
EONS 2020 highlights
1:13
EONS 2020 highlights
Matthew Fowler • 24 Sep 2020
Totally Implantable Vascular Access Device (TIVAD) service for patients with metastatic cancer
1:55
Totally Implantable Vascular Access Device (TIVAD) service for patients with metastatic cancer
Matthew Fowler • 29 Sep 2019
Cytotoxic contamination in wards
2:26
Cytotoxic contamination in wards
Matthew Fowler • 29 Sep 2019

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals